celltrion pharm 068760 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 068760 Date
Period 3 months 100-m won
2017.12 2018.12 2019.12 Average 2019.09 2019.12 2020.03 2020.06 2020.09 2020.12
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 1,359 1,469 1,735 1,521 474 449 444 464 461 458 458
O-profit 87 36 147 90 40 53 44 57 66 75 49
N-income 27 -94 86 6 20 43 22 39 58 85 31
O-rate 6.4 2.5 8.5 5.8 8.4 11.8 9.9 12.3 14.2 16.5 10.6
N-rate 2.0 -6.4 5.0 0.2 4.2 9.6 5.0 8.4 12.5 18.6 6.8
ROE 0.9 -3.5 3.1 0.2 2.9 4.5 3.5 4.1 4.6 5.2 3.8
Debt-ratio 60.1 67.6 68.2 65.3 65.5 68.2 73.1 75.5 79.2 83.0 70.6
Quick-ratio 117.3 102.3 104.6 108.1 106.4 104.6 100.5 96.8 105.2 131.8 102.1
reserve-ratio 1,653.3 1,486.5 1,539.4 1,559.7 1,514.1 1,539.4 1,469.3 1,492.7 1,499.0 1,515.4 1,503.9
EPS 75 -262 240 18 56 120 61 109 161 238 87
BPS 8,199 7,540 7,819 7,853 7,685 7,819 7,855 7,975 8,075 8,175 7,834
Dividends 0 0 0 0
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
2020-09-11
Gap
(Indication /
stock)
Color
High price ~ -48 %
High mid ~ -56 %
Mid ~ -65 %
Low mid ~ -73 %
Low price ~ -81 %
Normal
22,602 W 22,602 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 43 3,119 1,144
52,298 W 52,298 W 42,399 W
42,399 W 42,399 W 32,500 W Evaluation
62,196 W 62,196 W~ 52,298 W
120,000 W
41.432,500 W 32,500 W 22,602 W
High price
Indication price Range Current stock price Company score
22,602원
32,500원
42,399원
52,298원
62,196원
High price
120,000원
-81%
-73%
-65%
-56%
-48%
-90%
-80%
-70%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
0W
20,000W
40,000W
60,000W
80,000W
100,000W
120,000W
140,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
celltrion pharm
Gap
celltrion pharm

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 068760 Date
Period
Gap
(Indication /
stock)
Color
low price 22,602 W 22,602 W ~ 0 W -81 % 622,234 W 28
Low mid 32,500 W 32,500 W ~ 22,602 W -73 % 558,996 W 17
Mid 42,399 W 42,399 W ~ 32,500 W -65 % 495,759 W 12
High mid 52,298 W 52,298 W ~ 42,399 W -56 % 432,521 W 8
Suggested Purchase
Amount 766,628 W
Number of stocks
purchased 6
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 62,196 W 62,196 W~ ~ 52,298 W -48 % 369,283 W 6
2020-09-11
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
120,000 W High price 48.3 Normal 2,500,000 W
31.8 45.9 49.8 29.6 37.4 40.6
2020.04.17 2020.05.20 2020.06.17 2020.07.15 2020.08.12 2020.09.10
Stock price rise
probability score
A Sector 49.8 50.6 46.7 48.9 47.3 44.6
48.3B Sector 13.8 41.3 52.9 48.9 27.5 36.7
Total average
2020.06.17 2020.07.15 2020.08.12 2020.09.10
Total of
increase rate
Total score
A Sector 2 % -8 % 4 % -3 % -6 %
-0 % 51.3B Sector 67 % 22 % -8 % -78 % 25 %
Total average 31 % 8 % -68 % 21 % 8 %
2020.05.20
50 51
47 49 47
45
14
41
53
49
28
37
32
46
50
30
37
41
0
10
20
30
40
50
60
2020.04.17 2020.05.20 2020.06.17 2020.07.15 2020.08.12 2020.09.10
Stock price rise probability score
A sector
B sector
Total average
2%
-8%
4%
-3% -6%
67%
22%
-8%
-78%
25%31%
8%
-68%
21%
8%
-100%
-80%
-60%
-40%
-20%
0%
20%
40%
60%
80%
2020.05.20 2020.06.17 2020.07.15 2020.08.12 2020.09.10
Increase rate of stock price rise
A sector
B sector
Total average
celltrion pharm

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report